DRIO
Price
$1.52
Change
+$0.01 (+0.66%)
Updated
Mar 27, 6:59 PM EST
Earnings call today
POAI
Price
$2.78
Change
+$0.09 (+3.35%)
Updated
Mar 27, 6:59 PM EST
Ad is loading...

Compare trend and price DRIO vs POAI

Header iconDRIO vs POAI Comparison
Open Charts DRIO vs POAIBanner chart's image
DarioHealth
Price$1.52
Change+$0.01 (+0.66%)
Volume$96.71K
CapitalizationN/A
Predictive Oncology
Price$2.78
Change+$0.09 (+3.35%)
Volume$5.15K
CapitalizationN/A
View a ticker or compare two or three
DRIO vs POAI Comparison Chart

Loading...

DRIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
POAIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
DRIO vs. POAI commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRIO is a Hold and POAI is a StrongBuy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (DRIO: $1.49 vs. POAI: $2.78)
Brand notoriety: DRIO and POAI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DRIO: 112% vs. POAI: 44%
Market capitalization -- DRIO: $41.4M vs. POAI: $11.3M
DRIO [@Medical Specialties] is valued at $41.4M. POAI’s [@Medical Specialties] market capitalization is $11.3M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRIO’s FA Score shows that 1 FA rating(s) are green whilePOAI’s FA Score has 1 green FA rating(s).

  • DRIO’s FA Score: 1 green, 4 red.
  • POAI’s FA Score: 1 green, 4 red.
According to our system of comparison, both DRIO and POAI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRIO’s TA Score shows that 3 TA indicator(s) are bullish while POAI’s TA Score has 4 bullish TA indicator(s).

  • DRIO’s TA Score: 3 bullish, 6 bearish.
  • POAI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, POAI is a better buy in the short-term than DRIO.

Price Growth

DRIO (@Medical Specialties) experienced а +6.43% price change this week, while POAI (@Medical Specialties) price change was +7.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.02%. For the same industry, the average monthly price growth was -0.18%, and the average quarterly price growth was +4.58%.

Reported Earning Dates

DRIO is expected to report earnings on May 13, 2024.

POAI is expected to report earnings on May 17, 2023.

Industries' Descriptions

@Medical Specialties (+1.02% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for DRIO with price predictions.
OPEN
A.I.dvisor published
a Summary for POAI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DRIO($41.4M) has a higher market cap than POAI($11.3M). DRIO YTD gains are higher at: -13.372 vs. POAI (-15.502). POAI has higher annual earnings (EBITDA): -13.93M vs. DRIO (-49.57M). DRIO has more cash in the bank: 43.9M vs. POAI (11.9M). POAI has less debt than DRIO: POAI (3.16M) vs DRIO (29.9M). DRIO has higher revenues than POAI: DRIO (23.5M) vs POAI (1.81M).
DRIOPOAIDRIO / POAI
Capitalization41.4M11.3M366%
EBITDA-49.57M-13.93M356%
Gain YTD-13.372-15.50286%
P/E RatioN/AN/A-
Revenue23.5M1.81M1,299%
Total Cash43.9M11.9M369%
Total Debt29.9M3.16M947%
FUNDAMENTALS RATINGS
DRIO vs POAI: Fundamental Ratings
DRIO
POAI
OUTLOOK RATING
1..100
6652
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
8880
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DRIO's Valuation (30) in the Medical Specialties industry is in the same range as POAI (33) in the null industry. This means that DRIO’s stock grew similarly to POAI’s over the last 12 months.

DRIO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as POAI (100) in the null industry. This means that DRIO’s stock grew similarly to POAI’s over the last 12 months.

DRIO's SMR Rating (98) in the Medical Specialties industry is in the same range as POAI (98) in the null industry. This means that DRIO’s stock grew similarly to POAI’s over the last 12 months.

POAI's Price Growth Rating (80) in the null industry is in the same range as DRIO (88) in the Medical Specialties industry. This means that POAI’s stock grew similarly to DRIO’s over the last 12 months.

POAI's P/E Growth Rating (100) in the null industry is in the same range as DRIO (100) in the Medical Specialties industry. This means that POAI’s stock grew similarly to DRIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DRIOPOAI
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
DRIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
POAIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BYRN14.340.71
+5.21%
Byrna Technologies
CSX36.830.70
+1.94%
CSX Corp
DMLP33.930.60
+1.80%
Dorchester Minerals LP
PHI24.420.30
+1.24%
PLDT
SABS4.210.04
+0.96%
SAB Biotherapeutics

DRIO and

Correlation & Price change

A.I.dvisor tells us that DRIO and PACB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRIO and PACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRIO
1D Price
Change %
DRIO100%
-1.65%
PACB - DRIO
30%
Poorly correlated
+5.68%
TWST - DRIO
28%
Poorly correlated
+2.13%
IDXX - DRIO
28%
Poorly correlated
+1.70%
ARAY - DRIO
28%
Poorly correlated
+2.53%
ATEC - DRIO
27%
Poorly correlated
+2.91%
More

POAI and

Correlation & Price change

A.I.dvisor tells us that POAI and PSNL have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POAI and PSNL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POAI
1D Price
Change %
POAI100%
+4.12%
PSNL - POAI
28%
Poorly correlated
+1.40%
PLSE - POAI
26%
Poorly correlated
+1.82%
SENS - POAI
26%
Poorly correlated
+1.73%
BNGO - POAI
25%
Poorly correlated
+3.85%
MOVE - POAI
24%
Poorly correlated
-0.78%
More